Showing results (31-40 of 199) with videos related to

Sort By:
Pageof 20
Prostate Cancer|November 24, 2011
A comparison of radical perineal, radical retropubic, and robot-assisted laparoscopic prostatectomies in a single surgeon seriesMoben Mirza, Kevin Art, Logan Wineland, et al.
The Canadian Journal of Urology|April 15, 2009
Predictors of positive surgical margins after radical perineal prostatectomyManlio A Goetzl, Ron Krebill, Thomas L Griebling, et al.
American Journal of Clinical and Experimental Urology|November 7, 2014
PI-3 kinase p110β: a therapeutic target in advanced prostate cancersBenyi Li, Aijing Sun, Wencong Jiang, et al.
Nature Reviews. Urology|May 30, 2012
Cancer immunotherapy: a paradigm shift for prostate cancer treatmentDev Karan, Jeffrey M Holzbeierlein, Peter Van Veldhuizen, et al.
The Journal of Urology|September 28, 2002
Ejaculatory function in stage T1 nonseminomatous germ cell tumors: retroperitoneal lymph node dissection versus surveillance--a decision analysisPeter Langenstroer, Mark A Rosen, Tomas L Griebling, et al.
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|November 1, 1989
Pseudocyesis and depression. Etiological and treatment considerationsS Rubman, A J Goreczny, P J Brantley, et al.
International Journal of Environmental Research and Public Health|May 3, 2020
HEADS UP: Design and Methods of a Louisiana State-Funded Surgical and Non-Surgical Weight Loss ProgramPhillip J Brantley, Win Guan, Ricky Brock, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|June 12, 2001
The Attitudes Toward Women with HIV/AIDS Scale (ATWAS): development and validationE L O'Hea, S E Sytsma, A Copeland, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|March 5, 2005
Case selection and outcome of radical perineal prostatectomy in localized prostate cancerJeffrey M Holzbeierlein, Peter Langenstroer, H J Porter, et al.
Molecular Cancer Therapeutics|November 18, 2003
Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancerXinbo Liao, Liping Zhang, J Brantley Thrasher, et al.
Pageof 20